VERACYTE, INC.
Nasdaq · Services-Medical Laboratories
Company Overview
A concise company profile alongside the latest public filing activity.
Veracyte develops genomic tests that analyze tissue, blood, or other samples to help diagnose diseases such as thyroid, lung, and breast cancer, giving physicians information to guide treatment decisions and reduce unnecessary surgeries.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Febbo Phillip G.Chief Scientific & Med Officer | Sell | $446K | 10,405at $42.89 | Sep 4, 2026 |
| Febbo Phillip G.Chief Scientific & Med Officer | Sell | $118K | 2,705at $43.66 | Sep 4, 2026 |
| Chambers RebeccaChief Financial Officer | Sell | $106K | 2,477at $42.81 | Sep 4, 2026 |
| McGuire AnnieEVP, General Counsel | Sell | $92K | 2,154at $42.79 | Sep 4, 2026 |
| Chambers RebeccaChief Financial Officer | Sell | $51K | 1,175at $43.71 | Sep 4, 2026 |
| McGuire AnnieEVP, General Counsel | Sell | $48K | 1,100at $43.67 | Sep 4, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable VCYT activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.